BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16285332)

  • 1. Population Frequency of Fanconi Pathway Gene Variants and Their Association with Survival After Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    McReynolds LJ; Wang Y; Thompson AS; Ballew BJ; Kim J; Alter BP; Hicks B; Zhu B; Jones K; Spellman SR; Wang T; Lee SJ; Savage SA; Gadalla SM
    Biol Blood Marrow Transplant; 2020 May; 26(5):817-822. PubMed ID: 31982544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To determine the frequency of aldehyde dehydrogenase type 2 (aldh2) deficiency in aplastic anaemia: A single center experience from pakistan.
    Shamim N; Khan MA; Iftikhar R; Akram Z; Jamshaid H; Rehman J; Chaudhry QUN; Ghafoor T
    J Ayub Med Coll Abbottabad; 2023; 35(3):462-465. PubMed ID: 38404093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
    Gu Y; Estcourt LJ; Doree C; Trivella M; Hopewell S; Vyas P
    Cochrane Database Syst Rev; 2015 Mar; 3():. PubMed ID: 25983657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.
    Ashraf A; Hadjinicolaou AV; Doree C; Hopewell S; Trivella M; Estcourt LJ
    Cochrane Database Syst Rev; 2016 Sep; 2016(9):. PubMed ID: 27660553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management.
    Vissers LTW; van der Burg M; Lankester AC; Smiers FJW; Bartels M; Mohseny AB
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late chimerical status after bone marrow transplantation in severe aplastic anemia according to two different preparatory regimens.
    Quiroga M; Pereira NF; Bitencourt MA; Bonfim C; Monteiro MGM; Pasquini R
    Hematol Transfus Cell Ther; 2018; 40(2):112-119. PubMed ID: 30057984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
    Townsley DM; Desmond R; Dunbar CE; Young NS
    Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated donor marrow transplantation for severe aplastic anaemia.
    Howard MR
    Transfus Sci; 1991; 12(3):123-34. PubMed ID: 10149542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of bone marrow transplantation in acquired and inherited aplastic anaemia in the Republic of Ireland.
    Piccin A; O'Marcaigh A; Smith O; O'Riordan J; Crowley M; Vandenberg E; Gardiner N; McCann S
    Ir J Med Sci; 2005; 174(3):13-9. PubMed ID: 16285332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
    Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
    Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated donor marrow transplants for severe acquired aplastic anemia.
    Hows J; Szydlo R; Anasetti C; Camitta B; Gajewski J; Gluckman E
    Bone Marrow Transplant; 1992; 10 Suppl 1():102-6. PubMed ID: 1521081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplastic anaemia in childhood: prognosis and approach to therapy.
    Windass B; Vowels MR; Hughes DO; White L
    Med J Aust; 1987 Jan; 146(1):15-9. PubMed ID: 3540547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children.
    Locasciulli A; Vossen J; Bacigalupo A; Hows J; VanLint MT; Gluckman E; Nissen C; McCann S; de Planque M; van'tVeer L
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():123-5. PubMed ID: 2697423
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.